<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Extracutaneous manifestations and complications of inherited epidermolysis bullosa&lt;sup&gt;[1-13]&lt;/sup&gt;</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Extracutaneous manifestations and complications of inherited epidermolysis bullosa<sup>[1-13]</sup></h1>
<div class="graphic"><div class="figure"><div class="ttl">Extracutaneous manifestations and complications of inherited epidermolysis bullosa<sup>[1-13]</sup></div><div class="cntnt"><table cellspacing="0"><colgroup width="20%"></colgroup><colgroup width="60%"></colgroup><colgroup width="20%"></colgroup> <tbody> <tr> <td class="subtitle1">Organ system</td> <td class="subtitle1">Clinical features</td> <td class="subtitle1">Predominant EB subtypes</td> </tr> <tr> <td>Nail apparatus</td> <td> <ul> <li>Periungual or subungual blistering, hemorrhages and nail bed hyperkeratosis with onycholysis, onychomadesis; periodic nail shedding and regrowth with progressive onychodystrophy (EBS, JEB, DEB) +/â€“ onychogryphosis (EBS, JEB)</li> <li>Paronychia-like lesions and nail loss, with nail bed erosions and development of subungual and periungual granulation tissue soon after birth (severe JEB and JEB-LOC syndrome)</li> <li>Complete nail loss, nail bed and matrix scarring, mitten deformity (DEB)</li> <li>Thin, brittle, short, atrophic nails due to nail matrix damage by repetitive blistering (JEB, DEB)</li> <li>Few nails affected in localized DEB</li> <li>Autosomal dominant trait of toenail onychodystrophy in a child may be sign of DEB</li> <li>Parrot beak nail deformity from recurrent blistering in distal fingers resulting in soft tissue and bone reabsorption with nail bending around shortened fingertip (KEB)</li> </ul> </td> <td>Severe EBS subtypes (excluding localized EBS, EBS migratory circinate, severe EBS with pyloric atresia); most JEB patients; DEB</td> </tr> <tr> <td>Hair</td> <td> <ul> <li>Increased hair and skin fragility due to deficient stabilization of the upper permanent portion of the follicle (infundibulum, isthmus, bulge region) to the surrounding connective tissues (DEB)</li> <li>Cicatricial alopecia secondary to blistering (JEB, DEB) or infection involving interfollicular epidermis and upper portion of hair follicle</li> <li>Transient, reversible telogen effluvium due to anemia or sepsis</li> <li>Sparse, short, dry, curly, woolly hair; hypotrichosis</li> <li>Absent eyebrows and eyelashes (ectodermal dysplasia-skin fragility syndrome)</li> <li>Secondary scarring alopecia (JEB with pyloric atresia)</li> </ul> </td> <td>EBS, JEB, DEB</td> </tr> <tr> <td>Eye</td> <td> <ul> <li>Red, watery eyes, photophobia, ocular pain; conjunctival injection, edema, blisters; subconjunctival hemorrhage, blepharoconjunctivitis (severe RDEB; RDEB, inversa), exposure keratopathy</li> <li>Corneal bullae, erosion, ulceration, abrasions, pitting, opacities, scars; peripheral corneal vascularization, corneal pannus formation, limbal broadening, cornea plana, sclerocornea, cataracts</li> <li>Eyelid blisters or ectropion with exuberant granulation tissue (severe JEB), eyelid scarring, pseudopterygium, symblepharon (JEB, RDEB), ankyloblepharon</li> <li>Lacrimal duct obstruction (RDEB, inversa; severe JEB)</li> <li>Refractive errors, amblyopia, strabismus, lens subluxation, posterior vitreous detachment, impaired vision (severe RDEB; RDEB, inversa), blindness (severe RDEB)</li> </ul> </td> <td>Severe RDEB, intermediate RDEB, severe JEB, intermediate JEB</td> </tr> <tr> <td>Oral cavity</td> <td><strong>Soft tissues:</strong> <ul class="decimal_heading"> <li>Mucosal fragility, blistering, ulceration, mostly localized (EBS)</li> <li>Significant involvement and oral scarring (severe EBS)</li> <li>Variable blistering and ulceration; exuberant perioral granulation tissue resulting in a reduction of the oral opening (microstomia) and loss of tissue mobility in lips and perioral tissues (severe JEB)</li> <li>Involvement from mild to severe; extreme fragility evident shortly after birth with inability to suckle (severe RDEB, intermediate RDEB)</li> <li>Restricted oral aperture, ankyloglossia, obliteration of vestibules, loss of lingual papillae, ablated palatal rugae; intraoral keratocysts (milia), elevated risk for intraoral squamous cell carcinoma (severe RDEB)</li> <li>Early-onset periodontal disease, gingival inflammation and hyperplasia; sometimes severe oral blistering in neonates and infants, decreasing with age (KEB)</li> </ul> <p class="extra_spacing_top"><strong>Hard tissues:</strong></p> <ul class="decimal_heading"> <li>Normal dentition, caries risk not increased (EBS)</li> <li>Enamel lesions including pitting, horizontal hypoplastic bands, white mottled enamel, generalized hypoplasia, abnormal tooth eruption; increased risk of dental caries (JEB)</li> <li>Normal enamel (type VII collagen not expressed by ameloblasts); excessive dental caries, extensive tooth plaque formation and bacterial inoculation (DEB)</li> <li>Normal dentition; risk of dental caries unknown (KEB)</li> </ul> </td> <td>Severe RDEB, JEB, severe subtypes of EBS</td> </tr> <tr> <td>Gastrointestinal tract</td> <td> <ul> <li>Painful esophageal blistering, erosions, scarring, web formation, stenosis, strictures; hiatus hernia, abnormal esophageal peristalsis, atony, spontaneous perforation (severe RDEB)</li> <li>Gastroesophageal reflux disease common in more severe forms (RDEB, severe JEB, severe EBS, intermediate JEB) and prominent in pediatric populations; peptic ulcer disease</li> <li>Malabsorption, diarrhea; protein-losing enteropathy; irritable bowel disease; inflammatory bowel disease (EBS, DEB); diverticular disease; megacolon; colon perforation and peritonitis</li> <li>Rectal tears, prolapse, strictures; perianal fistulae; hemorrhoids, intussusception; megarectum</li> <li>Constipation</li> <li>Anemia, deficiencies of specific nutrients and vitamins (iron, selenium, zinc, vitamins A, B6, B12, C, D), hypoalbuminemia, osteoporosis/osteopenia</li> <li>Hypercatabolic state with failure to thrive (severe RDEB; severe JEB; severe EBS; intermediate JEB; RDEB, inversa; intermediate RDEB)</li> </ul> </td> <td>Severe RDEB; RDEB, inversa; severe JEB</td> </tr> <tr> <td>Genitourinary tract</td> <td> <ul> <li>Dysuria</li> <li>Blistering, fibrosis and scarring of glans penis; urethral meatal stenosis (RDEB); chronic inflammation of detrusor muscles secondary to exposure of denuded tissues to urine</li> <li>Urethral diverticula, penile and bulbar urethral strictures, hypospadias, epispadias</li> <li>Erosion or ulcerations on labia (RDEB, inversa), partial fusion of labia, narrowing of vaginal vestibule; urinary reflux into vagina and filling of uterine cavity</li> <li>Macroscopic blisters within the bladder, bladder edema, bladder cystitis, reduced bladder capacity, thickened bladder wall, bladder exstrophy</li> <li>Microscopic cleft formation within bladder, renal pelvis, ureter</li> <li>Urinary retention, stenosis or obstruction of the ureterovesical junction, ureteral fibrosis and stenosis, ureteral reflux with posterior urethral valves, hydroureter, hydronephrosis, renal pelvis stenosis, pyelocaliectasis, ureterectasis</li> <li>Pyelonephritis; poststreptococcal, IgA, or mesangial glomerulonephritis (RDEB); renal amyloidosis (RDEB); recurrent urinary tract infections, recurrent urosepsis</li> <li>Renal insufficiency and failure (severe RDEB)</li> </ul> </td> <td>Severe JEB, RDEB</td> </tr> <tr> <td>Ear, nose, throat, and upper airway</td> <td> <strong>Ear:</strong> <ul class="decimal_heading"> <li>Trauma-induced blistering, erosions, crusting on auricle and external auditory canal; secondary microbial colonization and infections (JEB), meatal scarring/stenosis (RDEB); auricular milia formation (DEB)</li> <li>Otitis media and externa (severe JEB; RDEB)</li> <li>Bilateral sensorineural deafness (RDEB)</li> </ul> <p class="extra_spacing_top"><strong>Nose:</strong></p> <ul class="decimal_heading"> <li>Erosions, crusting, around nares and within nostrils; rhinitis</li> <li>Granulation tissue (severe JEB) resulting in airway narrowing and repeated bleeding</li> <li>No increased frequency of atopy among any EB subtype</li> </ul> <p class="extra_spacing_top"><strong>Oropharynx:</strong></p> <ul class="decimal_heading"> <li>Blisters, erosions, scarring, stenosis (JEB; DEB)</li> </ul> <p class="extra_spacing_top"><strong>Larynx, trachea:</strong></p> <ul class="decimal_heading"> <li>Blisters, erosions, inflammation and soft tissue edema, scar formation along luminal surfaces including vocal cords (hoarse cry or voice; stridor); cysts; webbing, stenosis, strictures; complete or partial luminal occlusion secondary to exuberant granulation tissue with secondary aspiration pneumonitis or acute airway occlusion (severe JEB, JEB-LOC syndrome)</li> </ul> </td> <td>JEB (including JEB-LOC syndrome), RDEB</td> </tr> <tr> <td>Musculoskeletal system and heart</td> <td> <ul> <li>Pseudosyndactyly and total encasement of digits (severe RDEB; RDEB, inversa; infrequently in DDEB, intermediate JEB, severe EBS); contractures of hands (adduction contractures of thumb), feet, popliteal and antecubital fossae, and axillary vaults; progressive functional disability (difficulties in weight bearing, standing, walking; reduced fine manipulative skill; loss of digital prehension); muscle atrophy; bone absorption</li> <li>Osteopenia, osteoporosis (RDEB) consequent to restricted mobility and weight-bearing activity (painful skin wounds, contractures); impaired nutritional intake despite greater requirements (calcium, vitamin D, anemia); reduced sunlight exposure (restricted outdoor activities, extensive bandaging); induction of catabolic osteoclastic activity by proinflammatory cytokines in the course of chronic inflammation and chronic skin infection</li> <li>Cardiomyopathy (severe RDEB; rarely, intermediate RDEB; JEB) due to malnutrition and micronutrient (selenium and carnitine) deficiency, chronic anemia, transfusion-associated iron overload, viral myocarditis; precipitating or exacerbating cardiotoxic medications (amitriptyline, cisapride); may present in early childhood</li> </ul> </td> <td>Severe RDEB; RDEB, inversa</td> </tr> </tbody></table></div><div class="graphic_footnotes">DDEB: dominant dystrophic epidermolysis bullosa; 
    DEB: dystrophic epidermolysis bullosa; 
    EB: epidermolysis bullosa; 
    EBS: epidermolysis bullosa simplex; 
    JEB: junctional epidermolysis bullosa; 
    LOC: laryngo-oculo-cutaneous; 
    KEB: Kindler epidermolysis bullosa; 
    RDEB: recessive dystrophic epidermolysis bullosa.</div><div class="graphic_reference">References:
    <ol>
<li>Tosti A, de Farias DC, Murrell DF. Nail involvement in epidermolysis bullosa. Dermatol Clin 2010; 28:153.</li>
<li>Figueira EC, Murrell DF, Coroneo MT. Ophthalmic involvement in inherited epidermolysis bullosa. Dermatol Clin 2010; 28:143.</li>
<li>Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part I. Epithelial associated tissues. J Am Acad Dermatol 2009; 61:367.</li>
<li>Wright JT. Oral manifestations in the epidermolysis bullosa spectrum. Dermatol Clin 2010; 28:159.</li>
<li>Fine JD, Johnson LB, Weiner M, et al. Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience,1986-2006. J Am Acad Dermatol 2009; 60:203.</li>
<li>Shah N, Freeman E, Martinez A, et al. Histopathological features of gastrointestinal mucosal biopsy specimens in children with epidermolysis bullosa. J Clin Pathol 2007; 60:843.</li>
<li>Fine JD, Johnson LB, Weiner M, Suchindran C. Tracheolaryngeal complications of inherited epidermolysis bullosa: cumulative experience of the national epidermolysis bullosa registry. Laryngoscope 2007; 117:1652.</li>
<li>Fine JD, Mellerio JE. Extracutaneous manifestations and complications of inherited epidermolysis bullosa: part II. Other organs. J Am Acad Dermatol 2009; 61:387.</li>
<li>Lara-Corrales I, Mellerio JE, Martinez AE, et al. Dilated cardiomyopathy in epidermolysis bullosa: a retrospective, multicenter study. Pediatr Dermatol 2010; 27:238.</li>
<li>Has C, Bauer JW, Bodemer C, et al. Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility. Br J Dermatol 2020.</li>
<li>Fine JD, Bruckner-Tuderman L, Eady RA, et al. Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification. J Am Acad Dermatol 2014; 70:1103.</li>
<li>Robertson SJ, Prodinger C, Liu L, et al. Otological complications in inversa type recessive dystrophic epidermolysis bullosa. Clin Exp Dermatol 2022; 47:717.</li>
<li>Milani A, Pace A, Iannella G, et al. Recessive Dystrophic Epidermolysis Bullosa: Rare Bilateral External Auditory Canal Stenosis and Surgical Treatment. Clin Med Insights Case Rep 2022; 15:11795476221131196.</li>
</ol></div><div id="graphicVersion">Graphic 86396 Version 6.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
